<i>Ganoderma lucidum</i> Modulates Inflammatory Responses following 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Administration in Mice
<i>Ganoderma lucidum</i>, one of the most valued medicinal mushrooms, has been used for health supplements and medicine in China. Our previous studies have proved that <i>Ganoderma lucidum</i> extract (GLE) could inhibit activation of microglia and protect dopaminergic neuron...
Main Authors: | Zhili Ren, Hui Ding, Ming Zhou, Piu Chan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/14/18/3872 |
Similar Items
-
The role of microglial autophagy in Parkinson’s disease
by: Rui Zhu, et al.
Published: (2022-11-01) -
Optimized Extraction of Glycoproteins from <i>Ganoderma</i> <i>lucidum</i>
by: Naomi Tritean, et al.
Published: (2022-03-01) -
Bioactivity of Ganoderma lucidum and optimization of mycelial fermentation conditions
by: Li Zengmei, et al.
Published: (2023-01-01) -
<i>Ganoderma lucidum</i>-Derived Meroterpenoids Show Anti-Inflammatory Activity In Vitro
by: Yun-Yun Liu, et al.
Published: (2024-03-01) -
Does Ganoderma lucidum reduce obesity?
by: Ameneh Marzban, et al.
Published: (2022-11-01)